Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars
- PMID: 17553960
- PMCID: PMC1888575
- DOI: 10.1073/pnas.0703806104
Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars
Abstract
GABAergic dysfunction is present in the hippocampus in schizophrenia (SZ) and bipolar disorder (BD). The trisynaptic pathway was "deconstructed" into various layers of sectors CA3/2 and CA1 and gene expression profiling performed. Network association analysis was used to uncover genes that may be related to regulation of glutamate decarboxylase 67 (GAD(67)), a marker for this system that has been found by many studies to show decreased expression in SZs and BDs. The most striking change was a down-regulation of GAD(67) in the stratum oriens (SO) of CA2/3 in both groups; CA1 only showed changes in the SO of schizophrenics. The network generated for GAD(67) contained 25 genes involved in the regulation of kainate receptors, TGF-beta and Wnt signaling, as well as transcription factors involved in cell growth and differentiation. In SZs, IL-1beta, (GRIK2/3), TGF-beta2, TGF-betaR1, histone deacetylase 1 (HDAC1), death associated protein (DAXX), and cyclin D2 (CCND2) were all significantly up-regulated, whereas in BDs, PAX5, Runx2, LEF1, TLE1, and CCND2 were significantly down-regulated. In the SO of CA1 of BDs, where GAD67 showed no expression change, TGF-beta and Wnt signaling genes were all up-regulated, but other transcription factors showed no change in expression. In other layers/sectors, BDs showed no expression changes in these GAD(67) network genes. Overall, these results are consistent with the hypothesis that decreased expression of GAD(67) may be associated with an epigenetic mechanism in SZ. In BD, however, a suppression of transcription factors involved in cell differentiation may contribute to GABA dysfunction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolars.Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11731-6. doi: 10.1073/pnas.0903066106. Epub 2009 Jun 29. Proc Natl Acad Sci U S A. 2009. PMID: 19564623 Free PMC article.
-
Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars.Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20935-40. doi: 10.1073/pnas.0810153105. Epub 2008 Dec 22. Proc Natl Acad Sci U S A. 2008. PMID: 19104056 Free PMC article.
-
Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.JAMA Psychiatry. 2015 Jun;72(6):541-51. doi: 10.1001/jamapsychiatry.2015.49. JAMA Psychiatry. 2015. PMID: 25738424 Free PMC article.
-
Nicotinic receptors and functional regulation of GABA cell microcircuitry in bipolar disorder and schizophrenia.Handb Exp Pharmacol. 2012;(213):401-17. doi: 10.1007/978-3-642-25758-2_13. Handb Exp Pharmacol. 2012. PMID: 23027422 Review.
-
Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders.Neuropharmacology. 2011 Jun;60(7-8):1232-42. doi: 10.1016/j.neuropharm.2010.12.011. Epub 2010 Dec 22. Neuropharmacology. 2011. PMID: 21184762 Review.
Cited by
-
Limited predictability of postmortem human brain tissue quality by RNA integrity numbers.J Neurochem. 2016 Jul;138(1):53-9. doi: 10.1111/jnc.13637. Epub 2016 May 12. J Neurochem. 2016. PMID: 27062510 Free PMC article.
-
Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders.Front Cell Neurosci. 2016 Apr 5;10:89. doi: 10.3389/fncel.2016.00089. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27092053 Free PMC article. Review.
-
The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription.NPJ Schizophr. 2019 Jan 29;5(1):3. doi: 10.1038/s41537-019-0071-2. NPJ Schizophr. 2019. PMID: 30696826 Free PMC article.
-
Alterations in cortical interneurons and cognitive function in schizophrenia.Neurobiol Dis. 2019 Nov;131:104208. doi: 10.1016/j.nbd.2018.06.020. Epub 2018 Jun 22. Neurobiol Dis. 2019. PMID: 29936230 Free PMC article. Review.
-
Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine.Neuropsychopharmacology. 2019 Jun;44(7):1239-1246. doi: 10.1038/s41386-019-0328-5. Epub 2019 Feb 6. Neuropsychopharmacology. 2019. PMID: 30758327 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous